JP2020510011A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510011A5
JP2020510011A5 JP2019548370A JP2019548370A JP2020510011A5 JP 2020510011 A5 JP2020510011 A5 JP 2020510011A5 JP 2019548370 A JP2019548370 A JP 2019548370A JP 2019548370 A JP2019548370 A JP 2019548370A JP 2020510011 A5 JP2020510011 A5 JP 2020510011A5
Authority
JP
Japan
Prior art keywords
glucocorticoid receptor
patient
composition
composition according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019548370A
Other languages
English (en)
Japanese (ja)
Other versions
JP7564620B2 (ja
JP2020510011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021592 external-priority patent/WO2018165460A1/en
Publication of JP2020510011A publication Critical patent/JP2020510011A/ja
Publication of JP2020510011A5 publication Critical patent/JP2020510011A5/ja
Priority to JP2022070027A priority Critical patent/JP2022090003A/ja
Priority to JP2024053332A priority patent/JP2024074854A/ja
Application granted granted Critical
Publication of JP7564620B2 publication Critical patent/JP7564620B2/ja
Priority to JP2026061808A priority patent/JP2026099911A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019548370A 2017-03-09 2018-03-08 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 Active JP7564620B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022070027A JP2022090003A (ja) 2017-03-09 2022-04-21 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2024053332A JP2024074854A (ja) 2017-03-09 2024-03-28 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2026061808A JP2026099911A (ja) 2017-03-09 2026-04-03 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762469296P 2017-03-09 2017-03-09
US62/469,296 2017-03-09
PCT/US2018/021592 WO2018165460A1 (en) 2017-03-09 2018-03-08 Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022070027A Division JP2022090003A (ja) 2017-03-09 2022-04-21 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用

Publications (3)

Publication Number Publication Date
JP2020510011A JP2020510011A (ja) 2020-04-02
JP2020510011A5 true JP2020510011A5 (cg-RX-API-DMAC7.html) 2021-02-18
JP7564620B2 JP7564620B2 (ja) 2024-10-09

Family

ID=63446773

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019548370A Active JP7564620B2 (ja) 2017-03-09 2018-03-08 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2022070027A Withdrawn JP2022090003A (ja) 2017-03-09 2022-04-21 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2024053332A Withdrawn JP2024074854A (ja) 2017-03-09 2024-03-28 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2026061808A Pending JP2026099911A (ja) 2017-03-09 2026-04-03 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022070027A Withdrawn JP2022090003A (ja) 2017-03-09 2022-04-21 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2024053332A Withdrawn JP2024074854A (ja) 2017-03-09 2024-03-28 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用
JP2026061808A Pending JP2026099911A (ja) 2017-03-09 2026-04-03 カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用

Country Status (8)

Country Link
US (1) US11045482B2 (cg-RX-API-DMAC7.html)
EP (1) EP3592358A4 (cg-RX-API-DMAC7.html)
JP (4) JP7564620B2 (cg-RX-API-DMAC7.html)
CN (1) CN110475558A (cg-RX-API-DMAC7.html)
AU (1) AU2018230429B2 (cg-RX-API-DMAC7.html)
CA (1) CA3053806A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019010732A (cg-RX-API-DMAC7.html)
WO (1) WO2018165460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021007402A (es) 2018-12-20 2021-07-15 Corcept Therapeutics Inc Metodos para la toma de imagenes y el tratamiento de tumores positivos para el receptor de somatostatina.
JP2021079146A (ja) * 2021-02-22 2021-05-27 株式会社三洋物産 遊技機
JP7315071B2 (ja) * 2021-03-03 2023-07-26 株式会社三洋物産 遊技機

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606736D0 (en) 1996-02-19 1996-06-05 Shire International Licensing Therapeutic method
CA2246791A1 (en) 1998-09-01 2000-03-01 Alison Buchan Treatment of endothelium with somatostatin analogues
US6818739B2 (en) 1999-12-03 2004-11-16 Ndsu Research Foundation Somatostatins
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
JP2004525135A (ja) 2001-03-23 2004-08-19 コーセプト セラピューティクス, インコーポレイテッド 糖質コルチコイドレセプター特異的アンタゴニストを使用するストレス障害を処置するための方法
WO2003057214A1 (en) 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
RU28362U1 (ru) 2002-12-10 2003-03-20 Закрытое акционерное общество "Дальневосточная технология" Лист заходной футеровки
JP4931794B2 (ja) 2004-03-09 2012-05-16 コーセプト セラピューティクス, インコーポレイテッド 縮合環アザデカリン糖質コルチコイド受容体モジュレーター
GB0428151D0 (en) * 2004-12-22 2005-01-26 Novartis Ag Organic compounds
EP2145186A4 (en) * 2007-05-15 2010-10-20 Water Technologies Corp DEVICE AND METHOD FOR THE DETECTION OF METANEPHRINES IN PLASMA
EP2532350A1 (en) 2007-10-17 2012-12-12 Laboratoire HRA Pharma Pharmaceutical combination of a glucocorticoid receptor antagonist and a cortisol synthesis inhibitor for treating cushing's syndrome
ES2351569B8 (es) 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
AU2010247766B2 (en) 2009-05-12 2015-05-21 Corcept Therapeutics, Inc. Solid forms and process for preparing
WO2011094814A1 (en) * 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CN103596431B (zh) 2011-03-18 2016-06-22 科赛普特治疗公司 嘧啶环己基糖皮质激素受体调节剂
WO2013039916A1 (en) * 2011-09-12 2013-03-21 The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Compositions for and methods of treatment and enhanced detection of non-pituitary tumors
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
ES2943542T3 (es) 2013-11-25 2023-06-14 Corcept Therapeutics Inc Moduladores del receptor de glucocorticoides de azadecalina condensada con octahidro
JP6821582B2 (ja) * 2015-03-02 2021-01-27 コーセプト セラピューティクス, インコーポレイテッド Acth分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用
US9943526B2 (en) * 2015-04-21 2018-04-17 Corcept Therapeutics, Inc. Optimizing mifepristone levels for cushing's patients

Similar Documents

Publication Publication Date Title
JP2014240408A5 (cg-RX-API-DMAC7.html)
JP2018184417A5 (cg-RX-API-DMAC7.html)
RU2013102398A (ru) Лечение рака крови
TW200500355A (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
MXPA05012155A (es) Metodos y composiciones que utilizan compuestos inmunomoduladores para el tratamiento y manejo de canceres y otras enfermedades.
CA2939464A1 (en) Use of anti-ccr5 antibodies in graft versus host disease
WO2003097052A3 (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
NZ592039A (en) Combination therapy for the treatment of ocular neovascular disorders
MX2019013279A (es) Metodos de tratamiento del sindrome de doose utilizando fenfluramina.
MY199903A (en) Combination therapy with controlled-release cnp agonists
EA202191079A1 (ru) Способы лечения синдрома ретта с применением фенфлурамина
JP2012193216A5 (cg-RX-API-DMAC7.html)
MY150682A (en) Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
JP2015505564A5 (cg-RX-API-DMAC7.html)
IL320452A (en) Combination therapy for prostate cancer
JP2016507493A5 (cg-RX-API-DMAC7.html)
JP2020512361A5 (cg-RX-API-DMAC7.html)
JP2022116304A (ja) 血液がんの治療のためのPPARγアゴニスト
JP2017537927A5 (cg-RX-API-DMAC7.html)
JPWO2020250915A5 (cg-RX-API-DMAC7.html)
MX2020011295A (es) Tratamiento de dermatitis atopica.
JP2016515621A5 (cg-RX-API-DMAC7.html)
JP2022546456A5 (cg-RX-API-DMAC7.html)
JP2018502089A5 (cg-RX-API-DMAC7.html)
MX2025011882A (es) Metodos de tratamiento del cancer con un agonista del receptor de linfotoxina beta